my ||my url shorten
Link will be apear in 20 seconds.
Well done! you have successfully gained access to Decrypted Link.
Health : Copyright Free Content
New Technology Accesses Small But Mighty Microorganisms
(NewsUSA) – More medicines may be developed faster in the near future, thanks to new technology that harnesses the tiny particles that make drug development possible.Microorganisms grown in laboratories have been the starting poinmy url shortenmy url shortent for many medicines we have today. However, many more microorganisms exist in nature that can’t be grown in a lab because they are too small, too fragile, or evolve too rapidly. Also, microbes grown in culture behave differently than those extracted from the natural world, and are more limited in their ability to perform the chemical reactions that lead to drug discovery and product development.But Biosortia Pharmaceuticals has developed a novel way to access the previously hidden chemistry of microorganismsmy url shorten and capture small molecules directly from nature.Biosortia uses its technology to collect microbiomes in quantity and at quality, a concept known as microbiome mining. The microbiomes are becoming part of Biosortia’s growing library of patentable natural molecule activity and derivatives that can be used by various industries, including pharmaceutical, cosmetic, and agricultural, to solve problems and create products."Microbes are and have always been chemical researchers and factories of life," says Ross Youngs, founder and CEO of Biosortia.The ability of Biosortia to recover active microbiomes is creating "massive opportunities to explore the unknown," he says in a recent LinkedIn post.Biosortia’s microbiome mining approach has several advantages:– More options. Biosortia’s technology allows the my url shortencompany unprecedented access to previously unavailable molecules that have the potential for use in a range of inmy url shortendustries, and can provide a genomic roadmap to accompany data on the activity of the chemistry.– More efficiency. Biosortia accesses material from the microbiome in days, compared to the years needed by other researchers. In addition, the cost of Biosortia technology is significantly lower than traditional methods of microorganism development.– More success. Small molecules accessed directly from the microbiome are more likely to be successful in clinical development than those cultured in a lab because they have reached their potential in nature.Biorsortia continues to expand and has secured four patents to date, as well as a pending contract with the Department of Homeland Security. The Company’s science team publication technology has been peer-reviewed and received an Editor’s Choice Award from the American Chemical Society.For more information, visit fundable.com/biosortia.
Protect Your Health During Cancer Treatment
(NewsUSA) – Cancer can be a difficult and overwhelming diagnosis, and if you have cancer or are undergoing cancer treatment, your top priority is to get healthy. After your cancer diagnosis, there are many new things you might need to learn and manage. The Centers for Disease Control and Prevention and the National Blood Clot Alliance want you to protect your health by understanding your risk for dangerous blood clots, because cancer and some cancer treatments can increase your risk for blood clots. About 900,000 people each year are affected by blood clots, and about one in five of these blood clots are associated with cancer.The risk for a blood clot is greatest in the first few months after cancer is diagnosed. Some cancers pose a greater risk for blood clots, including cancers involving the pancreas, stomach, brain, lung, uterus, ovaries and kidneys, as well as blood cancers such as lymphoma and myeloma. The higher your cancer stage, the greater your risk for a blood clot. The type of cancer treatment you receive may increase your risk for blood clots too. Treatments involving hospitalization, surgery, chemotherapy, hormonal therapy, catheters placed in your veins, and some other therapies can increase your blood clot risk. Know the Signs and Symptoms of a Blood Clot Blood clots occur most often in the legs or arms, and symptoms include* Swelling.* Pain or tenderness not caused by an injury.* Skin that may be warm to the touch, red, or discolored.Blood clots in your legs or arms can travel to your lungs, which can be deadly. Symptoms of blood clots in your lungs include:* Difficulty breathing.* Chest pain that worsens with a deep breath.* Coughing up blood.* Faster than normal or irregular heartbeat.Contact your cancer doctor immediately if you experience any blood clot symptoms. A Plan to Protect Your Health As you take steps to preserve your health, make blood clot awareness part of your care.* Know your risks for blood clots, and discuss these risks with your cancer doctor.* Stay alert for any signs or symptoms of blood clots after surgery or treatment in an outpatient clinic. Contact your cancer doctor right away if you experience any of these signs or symptoms.* Work with your cancer doctor and make a plan to protect yourself against blood clots that is specific to your personal medical history and treatment.For more information, visit
World Heart Day Encourages People to Make Healthy Changes
(NewsUSA) – World Heart Day takes place each year on September 29.Founded in 2000 by the World Heart Federation, this specific day aims to increase awareness of heart disease and stroke worldwide. The American Heart Association, a global force for longer, healthier lives, is a founding member of the World Heart Federation and continues to work collaboratively to reduce premature deaths from noncommunicable diseases, such as heart disease.This year’s campaign, called "My Heart, Your Heart" is about celebrating and connecting like-minded people, and creating a sense of commitment around the common cause of heart health. It is a concept that encapsulates the values of World Heart Day through making a "Heart Promise" to improve your heart health by eating healthier, being more physically active and stopping smoking and/or vaping."World Heart Day is about what you can do to get, and keep, your heart healthy, and the American Heart Association is proud of the extensive work we do to provide the information to get you to optimal heart health," says Sidney Smith, M.D., volunteer medical expert and past president of the American Heart Association. "Through the areas of cardiovascular research, healthcare quality improvement and resuscitation science, the American Heart Association is committed to reducing deaths from cardiovascular disease."Cardiovascular disease is the leading global cause of death, accounting for more than 17.6 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030, according to a 2014 study. It accounts for approximately 1 of every 3 deaths and claims more lives each year than all forms of cancer combined. However, through making healthy behavior changes, it’s possible to greatly reduce the risk of cardiovascular disease and stroke.To learn more about World Heart Day and the World Heart Federation’s campaign, visit
Virologist’s Book Warns of Coming Lethal Flu Pandemic
(NewsUSA) – Scientists have long held that it will not be weapons of mass destruction that kills the human race, but rather a biological one.Case in point: the flu pandemic of 1918, colloquially known as the Spanish flu, occurred during World War I and spread worldwide during 1918-1919. Published research suggests the final death toll may have been as high as 100 million.Despite decades of developments in biology and virology at the cost of more than $80 billion, the U.S. is unprepared to handle a flu pandemic of a similar scale if one should occur, contends Dr. Steven Hatfill, a specialist physician and virologist with additional training in medical biochemistry, and experimental pathology.After more than a decade of study, Dr. Hatfill and his team have published a book, Three Seconds Until Midnight, in which he revisits the challenges of the 1918 pandemic and highlights the limitations of the current public health system in the U.S. in the event of a serious pandemic on the scale of the 1918 event."There are worse viruses out there in nature than another 1918-type pandemic. They are simply waiting for the right conditions to jump into man," says Dr. Hatfill.In addition, "the overwhelming majority of Americans assume that the CDC and public health authorities are capable of rapidly detecting when a new outbreak of infectious disease is occurring and that they will quickly respond with a vaccine, drugs, and other measures to contain the event. In reality, none of this is true with respect to a serious pandemic," he emphasizes.In the book, Dr. Hatfill and his team point out how the U.S. has an insufficient public health workforce and lacks the "surge" medical capacity needed for a pandemic situation with mass casualties, and that no programs are currently in place to train personnel how to handle a pandemic.Vaccine distribution is another problem, says Dr. Hatfill. Department of Health and Human Services (DHHS) documents show that in a pandemic on the scale of the 1918 event, a minimum of 123 to 125 million Americans will not receive any anti-viral drugs or vaccine until at or near the peak period of infection and death. Historically, the poor, socially disadvantaged urban communities will be hit the hardest.Citizens are uninformed on how to care for family members at home if they contract a contagious and possibly lethal infection, and entire households can become ill, Dr. Hatfill says.Dr. Hatfill’s book outlines how the government can salvage its preparedness plan by considering more involvement by the military in a disaster response mode, similar to the role played by the Armed Forces after Hurricane Katrina in 2005.The major problems in pandemic preparedness occur not with the federal government but with the local city authorities who continue to be unprepared to manage an outbreak of a serious lethal infectious disease on a 1918-type scale. This includes having rational methods to manage worker absenteeism, organizing alternate care sites, expanding mortuary capabilities and teaching non-pharmaceutical interventions to the public."We now live under population densities that are a new phenomenon in human civilization and we have no precedent to indicate if we are nearing a threshold or not". As a consequence, every individual alive today is participating in a great on-going global biological experiment," says Dr. Hatfill.Three Seconds Until Midnight will be available for purchase online via Amazon or Kindle in approximately mid-October. For more information, visit
Copper Can Help You Cope with Colds
(NewsUSA) – Finding relief for the common cold remains frustrating for doctors and cold sufferers alike. However, a simple copper device may help prevent colds and reduce the spread of infection.The science behind the CopperZap device is that bacteria, viruses, and other microbes die quickly on copper surfaces. Researchers believe copper’s high electrical conductance interferes with the delicate balance of a microbe cell and destroys it in seconds.In fact, some hospitals are experimenting with adding copper to high-touch surfaces such as faucets and call buttons to help kill bacteria on contact and reduce the spread of infection, according to a recent story in The Washington Post.CopperZap is a tool made of pure copper with a nasal probe at one end. The probe is designed to be rubbed gently in the nose for 60 seconds at the first sign of a cold coming on. In addition, touching the device can help kill illness-causing bacteria on the hands and fingers."Copper is great at killing superbugs," says Dr. Bill Keevil, a pioneer in researching copper and infectious diseases.In particular, copper can kill a type of virus known as a coronavirus that causes respiratory problems ranging from the mild discomfort of a common cold to potentially lethal pneumonia, according to Dr. Keevil. Other researchers have found that copper is effective against flu viruses and methicillin-resistant staphylococcus aureus (MRSA).Copper has been used for a variety of health purposes since ancient times; evidence suggests that Egyptians and Greeks used it to purify water and to disinfect ulcers and other infections on the skin. Reports from the Civil War document the use of copper to promote healing in battlefield wounds.In 2012, Dr. Doug Cornell, PhD, an American inventor, learned about the microbe-killing power of copper and saw the potential for a handheld device to combat viruses. Dr. Cornell designed the CopperZap to combat cold and flu viruses in the nose and on the fingers."Over 99 percent of people who used it and reported results say it worked to stop a cold they felt about to start," Dr. Cornell says. Other users report that the CopperZap has stopped flu symptoms, cured cold sores, and relieved sinus discomfort, he adds.For more information, visit copperzap.com.
Helping Manage The Cost of Asthma And COPD Inhalers
(NewsUSA) – With the intense summer heat and horrible air quality, some people across the California Central Valley and other areas of the country are finding it difficult to breathe. When this happens, they quickly turn to their asthma or chronic obstructive pulmonary disease (COPD) inhalers. Greater use of these devices means more refills are needed.For many middle-class families, the ongoing out-of-pocket costs for asthma or COPD medications is a growing burden. When money runs low, some people will try to stretch the use of their inhalers for as long as possible; others try to get by without them at all, placing their health at risk.Asthma affects about one in every 13 Americans, one-fourth of whom are under the age of 18. It is the third-leading cause of hospital stays for children. COPD is a group of progressive lung diseases that obstructs airflow. Some 16 million Americans suffer from COPD, 70 percent of whom are 45 and older.While many patients and caregivers struggle with these complex conditions, the high-cost insurance premiums, along with steep deductibles, copays, and poor prescription coverage, can prove a significant barrier. This is compounded by the fact that 75 percent of patients are not taking their medication correctly. And the impact of nonadherence can mean a visit to the hospital.Asthma and COPD require an arsenal of medications. And, it is not uncommon for people suffering from one of these conditions to be impacted by other chronic conditions.Rather than point fingers at medication costs or insurance company profits, it is important to help people find solutions.Copay assistance cards, also called copay coupons, can help take the financial sting out of the cost of medito obtain one, and look for the button, " Click for Asthma and COPD Recommendations."Please remember to start with your local pharmacist. He or she is the most informed about prescription medications.And if you are uninsured, there are programs that often cover close to 100 percent of your costs. Try this website, mat.org, offered by the pharmaceutical manufacturer’s trade association.Cost should never be a barrier to care.Jeffrey Lewis is president and CEO of Legacy Health Endowment in Turlock Ca.Mr. Lewis’ email address is jeffrey@legacyhealthendowment.org
Helping Valley People Manage The Cost of Insulin
(NewsUSA) – Middle-class families are being devastated by the staggering cost of life-saving insulin.While the average person spends about $1,025 per year on medication, many people with diabetes who use insulin are often required by their health insurance plans to spend five times that amount on a treatment they must have.Today, six million Americans who depend on insulin to manage their diabetes often need multiple insulin shots a day. Many are choosing to forego their insulin or to ration doses, risking greater health problems. The cause? Insufficient prescription drug coverage by insurance carriers.Lost in this complex world of diabetes, amid the blame game and finger-pointing, are programs created by pharmaceutical manufacturers to help patients enrolled in private health insurance plans who cannot afford their prescriptions. Many insurers fail to tell people about these programs.Copay assistance cards, also called copay coupons, can help take the financial sting out of the cost of medication. To obtain one, patients must go to the insulin manufacturer’s website and search for financial or copay assistance programs, complete an application, and enroll.All of this can be a bit complicated; many people get frustrated and give up. Don’t!The value of copay assistance is this: it lowers the cost you pay and may even cover all the cost. The pharmaceutical company covers the difference. Typically, you don’t even have to prove that paying your regular copay would present a financial hardship. These programs are usually not available to Medicare recipients, however.To help people in the California Central Valley afford their insulin, we looked up programs offered by pharmaceutical companies that manufacture insulin.For more information on Insulin Support Programs, visit cover close to 100 percent of the cost. The Mat.org website is a great website to help you.Before filling your insulin prescription or any prescription medication, check to see if the pharmaceutical manufacturer offers a copay assistance program. If you need help, remember that your pharmacist is another excellent resource and may be able to answer your questions.Jeffrey Lewis is president and CEO of Legacy Health Endowment in Turlock Ca.Mr. Lewis’ email address is jeffrey@legacyhealthendowment.org
Taking Control of Distressing Low Sexual Desire: A Patient’s Journey
(NewsUSA) – For Amy, living with acquired generalized hypoactive sexual desire disorder (HSDD) was stressful. Acquired, generalized HSDD means that you have not had low sexual desire in the past and that you now have low sexual desire, no matter the sexual activity, situation, or sexual partner.She and her husband tried different types of stimulation, but nothing got her in the mood. "My lack of interest in sex was hard on my marriage. My husband wanted to be intimate, but I didn’t. I missed that connection with him."Amy is not alone in her experience. HSDD is a diagnosable medical condition that affects approximately 1 in 10 women in the U.S., with a profound impact on a woman’s emotional state, her sense of self and her relationships."Trying to deal with the strain of low sexual desire was difficult. I talked to my husband about it and we looked for solutions together. Eventually, my doctor helped me enroll in a clinical trial for an HSDD investigational treatment.""In the clinical trial, I received training on how to use an autoinjector to take the medicine at least 45 minutes before I anticipated sexual activity. I found the injection easy to use, it fit conveniently into my schedule and it put me in the driver’s seat for when I wanted to take the medication. I felt empowered when my desire returned and started to look forward to being intimate with my husband again."Following the clinical trial, Amy hoped she would one day have the choice of taking the medication again. In June 2019, the U.S. Food and Drug Administration (FDA) approved Vyleesi™ (bremelanotide injection) to treat hypoactive (low) sexual desire disorder (HSDD) in certain premenopausal women. Vyleesi is not indicated for the enhancement of sexual performance, but women will have another treatment option for HSDD when Vyleesi is available later this month.In the clinical trials, the most common side effects were nausea, flushing, injection site reactions, headache and vomiting. Vyleesi should not be used by women with uncontrolled high blood pressure or heart disease.AMAG Pharmaceuticals, the company launching Vyleesi, will offer co-pay assistance to help women access Vyleesi. Patients will be able to obtain their first four-pack of Vyleesi autoinjectors with a $0 co-pay, and refills for no more than $99. Under current government regulations, pharmaceutical companies cannot offer this type of program to patients insured by federal health care programs, including Medicare and Medicaid.Amy says, "I am motivated to share my story because I want to encourage other women to talk to their healthcare providers about distressing low sexual desire and find out what treatment options are available. They should know they do not have to suffer in silence."Women who may be experiencing symptoms are encouraged to visit Vyleesi.com and utilize a tool called the HSDD Symptom Checker. To verify diagnosis and to see if Vyleesi might be an appropriate treatment option for them, women are encouraged to speak with their healthcare provider (HCP). An open and honest conversation between a woman and her HCP is the first step to improving desire, reducing distress and getting back to a fulfilling sex life – something all women deserve.IMPORTANT SAFETY INFORMATIONDo not use VYLEESI if you have uncontrolled hypertension, known heart disease or are taking oral naltrexone-containing products intended to treat opioid or alcohol addiction. Women who can become pregnant should use effective birth control during treatment with VYLEESI.VYLEESI can cause serious side effects, including temporary increase in blood pressure and decrease in heart rate, severe nausea, and skin darkening that might be permanent.The most common side effects of VYLEESI include nausea, flushing, injection site reactions, headache, and vomiting. But these are not all the possible side effects of VYLEESI; consult your healthcare professional for more information or visit Vyleesi.com for additional Important Safety Information.You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.
Taking Control of Distressing Low Sexual Desire: A Patient’s Journey
(NewsUSA) – For Amy, living with acquired generalized hypoactive sexual desire disorder (HSDD) was stressful. Acquired, generalized HSDD means that you have not had low sexual desire in the past and that you now have low sexual desire, no matter the sexual activity, situation, or sexual partner.She and her husband tried different types of stimulation, but nothing got her in the mood. "My lack of interest in sex was hard on my marriage. My husband wanted to be intimate, but I didn’t. I missed that connection with him."Amy is not alone in her experience. HSDD is a diagnosable medical condition that affects approximately 1 in 10 women in the U.S., with a profound impact on a woman’s emotional state, her sense of self and her relationships."Trying to deal with the strain of low sexual desire was difficult. I talked to my husband about it and we looked for solutions together. Eventually, my doctor helped me enroll in a clinical trial for an HSDD investigational treatment.""In the clinical trial, I received training on how to use an autoinjector to take the medicine at least 45 minutes before I anticipated sexual activity. I found the injection easy to use, it fit conveniently into my schedule and it put me in the driver’s seat for when I wanted to take the medication. I felt empowered when my desire returned and started to look forward to being intimate with my husband again."Following the clinical trial, Amy hoped she would one day have the choice of taking the medication again. In June 2019, the U.S. Food and Drug Administration (FDA) approved Vyleesi™ (bremelanotide injection) to treat hypoactive (low) sexual desire disorder (HSDD) in certain premenopausal women. Vyleesi is not indicated for the enhancement of sexual performance, but women will have another treatment option for HSDD when Vyleesi is available later this month.In the clinical trials, the most common side effects were nausea, flushing, injection site reactions, headache and vomiting. Vyleesi should not be used by women with uncontrolled high blood pressure or heart disease.AMAG Pharmaceuticals, the company launching Vyleesi, will offer co-pay assistance to help women access Vyleesi. Patients will be able to obtain their first four-pack of Vyleesi autoinjectors with a $0 co-pay, and refills for no more than $99. Under current government regulations, pharmaceutical companies cannot offer this type of program to patients insured by federal health care programs, including Medicare and Medicaid.Amy says, "I am motivated to share my story because I want to encourage other women to talk to their healthcare providers about distressing low sexual desire and find out what treatment options are available. They should know they do not have to suffer in silence."Women who may be experiencing symptoms are encouraged to visit Vyleesi.com and utilize a tool called the HSDD Symptom Checker. To verify diagnosis and to see if Vyleesi might be an appropriate treatment option for them, women are encouraged to speak with their healthcare provider (HCP). An open and honest conversation between a woman and her HCP is the first step to improving desire, reducing distress and getting back to a fulfilling sex life – something all women deserve.IMPORTANT SAFETY INFORMATIONDo not use VYLEESI if you have uncontrolled hypertension, known heart disease or are taking oral naltrexone-containing products intended to treat opioid or alcohol addiction. Women who can become pregnant should use effective birth control during treatment with VYLEESI.VYLEESI can cause serious side effects, including temporary increase in blood pressure and decrease in heart rate, severe nausea, and skin darkening that might be permanent.The most common side effects of VYLEESI include nausea, flushing, injection site reactions, headache, and vomiting. But these are not all the possible side effects of VYLEESI; consult your healthcare professional for more information or visit Vyleesi.com for additional Important Safety Information.You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.
Need for Donor Registry Prompts Nobel Nomination
(NewsUSA) – When Dr. Bart Fisher’s son, Ivan, was diagnosed with a rare blood disorder in 1983 at eight-years-old, the only cure was a bone marrow transplant. However, at that time, there was only a small bone marrow registry in England, with 50,000 names and, in the U.S., no registry at all to find a match.Since Ivan’s death, Dr. Fisher has made it his mission to establish large marrow registries around the world that would provide the gift of life to those in need of marrow transplantation.Underscoring the need for a donor registry is the fact that every nine minutes an American dies from a blood cancer such as leukemia, lymphoma, or myeloma. In 2018 alone, there were 174,250 new blood cancer cases."I tried to take a personal disaster and turn it into a mechanism that could save the lives of others needing a marrow match," says Dr. Fisher, a Washington D.C. lawyer, and PhD.Now, due in large part to Dr. Fisher’s efforts, the National Marrow Donor Program and other marrow registries match voluntary marrow donors with patients in need of a bone marrow transplant, as well as those who have marrow failure. Since the formation of the program in 1986, more than 80,000 transplants have taken place as a result of matches found by marrow registries and over 6,200 transplants a year are performed.According to Dr. Robert K. Stuart, Ivan’s doctor, the registry was needed long before it became a reality."The skeptics said we need to develop the technology before we would be ready for a registry. But what people don’t realize is that creating the registry is what drove the technology development. We would not be where we are if we had waited to create the registry later," he says.In addition to his work to create an international registry, Dr. Fisher co-founded the Give Life Foundation, which seeks to expand the base of voluntary organ donors for the worldwide registries. In turn, the Foundation has launched the Swab for Life campaign, a program that promotes registries through pharmacies, dentists’ offices, and doctors’ offices.For his tireless efforts, the Aplastic Anemia and MDS International Foundation (AAMDS) has nominated Dr. Fisher, its founder and a member of its Board of Directors, for a 2019 Nobel Prize in two categories: peace and medicine."The Nobel Prize nomination recognizes the significant contributions of Dr. Fisher to the establishment and growth of marrow registries around the world, and we are pleased and honored to support his efforts to advance this life-saving cure for aplastic anemia, leukemia, and other blood cancers," says Neil Horikoshi, executive director and CEO of the Aplastic Anemia and MDS International Foundation."I am honored to receive this nomination on behalf of my son, knowing that the work I have done has helped thousands of people in need. That it will continue to save lives is a legacy to Ivan’s memory."To find out more about the Foundation and its mission, as well as resources available, visit
New Technology Accesses Small But Mighty Microorganisms
(NewsUSA) – More medicines may be developed faster in the near future, thanks to new technology that harnesses the tiny particles that make drug development possible.Microorganisms grown in laboratories have been the starting poinmy url shortenmy url shortent for many medicines we have today. However, many more microorganisms exist in nature that can’t be grown in a lab because they are too small, too fragile, or evolve too rapidly. Also, microbes grown in culture behave differently than those extracted from the natural world, and are more limited in their ability to perform the chemical reactions that lead to drug discovery and product development.But Biosortia Pharmaceuticals has developed a novel way to access the previously hidden chemistry of microorganismsmy url shorten and capture small molecules directly from nature.Biosortia uses its technology to collect microbiomes in quantity and at quality, a concept known as microbiome mining. The microbiomes are becoming part of Biosortia’s growing library of patentable natural molecule activity and derivatives that can be used by various industries, including pharmaceutical, cosmetic, and agricultural, to solve problems and create products."Microbes are and have always been chemical researchers and factories of life," says Ross Youngs, founder and CEO of Biosortia.The ability of Biosortia to recover active microbiomes is creating "massive opportunities to explore the unknown," he says in a recent LinkedIn post.Biosortia’s microbiome mining approach has several advantages:– More options. Biosortia’s technology allows the my url shortencompany unprecedented access to previously unavailable molecules that have the potential for use in a range of inmy url shortendustries, and can provide a genomic roadmap to accompany data on the activity of the chemistry.– More efficiency. Biosortia accesses material from the microbiome in days, compared to the years needed by other researchers. In addition, the cost of Biosortia technology is significantly lower than traditional methods of microorganism development.– More success. Small molecules accessed directly from the microbiome are more likely to be successful in clinical development than those cultured in a lab because they have reached their potential in nature.Biorsortia continues to expand and has secured four patents to date, as well as a pending contract with the Department of Homeland Security. The Company’s science team publication technology has been peer-reviewed and received an Editor’s Choice Award from the American Chemical Society.For more information, visit fundable.com/biosortia.
Protect Your Health During Cancer Treatment
(NewsUSA) – Cancer can be a difficult and overwhelming diagnosis, and if you have cancer or are undergoing cancer treatment, your top priority is to get healthy. After your cancer diagnosis, there are many new things you might need to learn and manage. The Centers for Disease Control and Prevention and the National Blood Clot Alliance want you to protect your health by understanding your risk for dangerous blood clots, because cancer and some cancer treatments can increase your risk for blood clots. About 900,000 people each year are affected by blood clots, and about one in five of these blood clots are associated with cancer.The risk for a blood clot is greatest in the first few months after cancer is diagnosed. Some cancers pose a greater risk for blood clots, including cancers involving the pancreas, stomach, brain, lung, uterus, ovaries and kidneys, as well as blood cancers such as lymphoma and myeloma. The higher your cancer stage, the greater your risk for a blood clot. The type of cancer treatment you receive may increase your risk for blood clots too. Treatments involving hospitalization, surgery, chemotherapy, hormonal therapy, catheters placed in your veins, and some other therapies can increase your blood clot risk. Know the Signs and Symptoms of a Blood Clot Blood clots occur most often in the legs or arms, and symptoms include* Swelling.* Pain or tenderness not caused by an injury.* Skin that may be warm to the touch, red, or discolored.Blood clots in your legs or arms can travel to your lungs, which can be deadly. Symptoms of blood clots in your lungs include:* Difficulty breathing.* Chest pain that worsens with a deep breath.* Coughing up blood.* Faster than normal or irregular heartbeat.Contact your cancer doctor immediately if you experience any blood clot symptoms. A Plan to Protect Your Health As you take steps to preserve your health, make blood clot awareness part of your care.* Know your risks for blood clots, and discuss these risks with your cancer doctor.* Stay alert for any signs or symptoms of blood clots after surgery or treatment in an outpatient clinic. Contact your cancer doctor right away if you experience any of these signs or symptoms.* Work with your cancer doctor and make a plan to protect yourself against blood clots that is specific to your personal medical history and treatment.For more information, visit
World Heart Day Encourages People to Make Healthy Changes
(NewsUSA) – World Heart Day takes place each year on September 29.Founded in 2000 by the World Heart Federation, this specific day aims to increase awareness of heart disease and stroke worldwide. The American Heart Association, a global force for longer, healthier lives, is a founding member of the World Heart Federation and continues to work collaboratively to reduce premature deaths from noncommunicable diseases, such as heart disease.This year’s campaign, called "My Heart, Your Heart" is about celebrating and connecting like-minded people, and creating a sense of commitment around the common cause of heart health. It is a concept that encapsulates the values of World Heart Day through making a "Heart Promise" to improve your heart health by eating healthier, being more physically active and stopping smoking and/or vaping."World Heart Day is about what you can do to get, and keep, your heart healthy, and the American Heart Association is proud of the extensive work we do to provide the information to get you to optimal heart health," says Sidney Smith, M.D., volunteer medical expert and past president of the American Heart Association. "Through the areas of cardiovascular research, healthcare quality improvement and resuscitation science, the American Heart Association is committed to reducing deaths from cardiovascular disease."Cardiovascular disease is the leading global cause of death, accounting for more than 17.6 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030, according to a 2014 study. It accounts for approximately 1 of every 3 deaths and claims more lives each year than all forms of cancer combined. However, through making healthy behavior changes, it’s possible to greatly reduce the risk of cardiovascular disease and stroke.To learn more about World Heart Day and the World Heart Federation’s campaign, visit
Virologist’s Book Warns of Coming Lethal Flu Pandemic
(NewsUSA) – Scientists have long held that it will not be weapons of mass destruction that kills the human race, but rather a biological one.Case in point: the flu pandemic of 1918, colloquially known as the Spanish flu, occurred during World War I and spread worldwide during 1918-1919. Published research suggests the final death toll may have been as high as 100 million.Despite decades of developments in biology and virology at the cost of more than $80 billion, the U.S. is unprepared to handle a flu pandemic of a similar scale if one should occur, contends Dr. Steven Hatfill, a specialist physician and virologist with additional training in medical biochemistry, and experimental pathology.After more than a decade of study, Dr. Hatfill and his team have published a book, Three Seconds Until Midnight, in which he revisits the challenges of the 1918 pandemic and highlights the limitations of the current public health system in the U.S. in the event of a serious pandemic on the scale of the 1918 event."There are worse viruses out there in nature than another 1918-type pandemic. They are simply waiting for the right conditions to jump into man," says Dr. Hatfill.In addition, "the overwhelming majority of Americans assume that the CDC and public health authorities are capable of rapidly detecting when a new outbreak of infectious disease is occurring and that they will quickly respond with a vaccine, drugs, and other measures to contain the event. In reality, none of this is true with respect to a serious pandemic," he emphasizes.In the book, Dr. Hatfill and his team point out how the U.S. has an insufficient public health workforce and lacks the "surge" medical capacity needed for a pandemic situation with mass casualties, and that no programs are currently in place to train personnel how to handle a pandemic.Vaccine distribution is another problem, says Dr. Hatfill. Department of Health and Human Services (DHHS) documents show that in a pandemic on the scale of the 1918 event, a minimum of 123 to 125 million Americans will not receive any anti-viral drugs or vaccine until at or near the peak period of infection and death. Historically, the poor, socially disadvantaged urban communities will be hit the hardest.Citizens are uninformed on how to care for family members at home if they contract a contagious and possibly lethal infection, and entire households can become ill, Dr. Hatfill says.Dr. Hatfill’s book outlines how the government can salvage its preparedness plan by considering more involvement by the military in a disaster response mode, similar to the role played by the Armed Forces after Hurricane Katrina in 2005.The major problems in pandemic preparedness occur not with the federal government but with the local city authorities who continue to be unprepared to manage an outbreak of a serious lethal infectious disease on a 1918-type scale. This includes having rational methods to manage worker absenteeism, organizing alternate care sites, expanding mortuary capabilities and teaching non-pharmaceutical interventions to the public."We now live under population densities that are a new phenomenon in human civilization and we have no precedent to indicate if we are nearing a threshold or not". As a consequence, every individual alive today is participating in a great on-going global biological experiment," says Dr. Hatfill.Three Seconds Until Midnight will be available for purchase online via Amazon or Kindle in approximately mid-October. For more information, visit
Copper Can Help You Cope with Colds
(NewsUSA) – Finding relief for the common cold remains frustrating for doctors and cold sufferers alike. However, a simple copper device may help prevent colds and reduce the spread of infection.The science behind the CopperZap device is that bacteria, viruses, and other microbes die quickly on copper surfaces. Researchers believe copper’s high electrical conductance interferes with the delicate balance of a microbe cell and destroys it in seconds.In fact, some hospitals are experimenting with adding copper to high-touch surfaces such as faucets and call buttons to help kill bacteria on contact and reduce the spread of infection, according to a recent story in The Washington Post.CopperZap is a tool made of pure copper with a nasal probe at one end. The probe is designed to be rubbed gently in the nose for 60 seconds at the first sign of a cold coming on. In addition, touching the device can help kill illness-causing bacteria on the hands and fingers."Copper is great at killing superbugs," says Dr. Bill Keevil, a pioneer in researching copper and infectious diseases.In particular, copper can kill a type of virus known as a coronavirus that causes respiratory problems ranging from the mild discomfort of a common cold to potentially lethal pneumonia, according to Dr. Keevil. Other researchers have found that copper is effective against flu viruses and methicillin-resistant staphylococcus aureus (MRSA).Copper has been used for a variety of health purposes since ancient times; evidence suggests that Egyptians and Greeks used it to purify water and to disinfect ulcers and other infections on the skin. Reports from the Civil War document the use of copper to promote healing in battlefield wounds.In 2012, Dr. Doug Cornell, PhD, an American inventor, learned about the microbe-killing power of copper and saw the potential for a handheld device to combat viruses. Dr. Cornell designed the CopperZap to combat cold and flu viruses in the nose and on the fingers."Over 99 percent of people who used it and reported results say it worked to stop a cold they felt about to start," Dr. Cornell says. Other users report that the CopperZap has stopped flu symptoms, cured cold sores, and relieved sinus discomfort, he adds.For more information, visit copperzap.com.
Helping Manage The Cost of Asthma And COPD Inhalers
(NewsUSA) – With the intense summer heat and horrible air quality, some people across the California Central Valley and other areas of the country are finding it difficult to breathe. When this happens, they quickly turn to their asthma or chronic obstructive pulmonary disease (COPD) inhalers. Greater use of these devices means more refills are needed.For many middle-class families, the ongoing out-of-pocket costs for asthma or COPD medications is a growing burden. When money runs low, some people will try to stretch the use of their inhalers for as long as possible; others try to get by without them at all, placing their health at risk.Asthma affects about one in every 13 Americans, one-fourth of whom are under the age of 18. It is the third-leading cause of hospital stays for children. COPD is a group of progressive lung diseases that obstructs airflow. Some 16 million Americans suffer from COPD, 70 percent of whom are 45 and older.While many patients and caregivers struggle with these complex conditions, the high-cost insurance premiums, along with steep deductibles, copays, and poor prescription coverage, can prove a significant barrier. This is compounded by the fact that 75 percent of patients are not taking their medication correctly. And the impact of nonadherence can mean a visit to the hospital.Asthma and COPD require an arsenal of medications. And, it is not uncommon for people suffering from one of these conditions to be impacted by other chronic conditions.Rather than point fingers at medication costs or insurance company profits, it is important to help people find solutions.Copay assistance cards, also called copay coupons, can help take the financial sting out of the cost of medito obtain one, and look for the button, " Click for Asthma and COPD Recommendations."Please remember to start with your local pharmacist. He or she is the most informed about prescription medications.And if you are uninsured, there are programs that often cover close to 100 percent of your costs. Try this website, mat.org, offered by the pharmaceutical manufacturer’s trade association.Cost should never be a barrier to care.Jeffrey Lewis is president and CEO of Legacy Health Endowment in Turlock Ca.Mr. Lewis’ email address is jeffrey@legacyhealthendowment.org
Helping Valley People Manage The Cost of Insulin
(NewsUSA) – Middle-class families are being devastated by the staggering cost of life-saving insulin.While the average person spends about $1,025 per year on medication, many people with diabetes who use insulin are often required by their health insurance plans to spend five times that amount on a treatment they must have.Today, six million Americans who depend on insulin to manage their diabetes often need multiple insulin shots a day. Many are choosing to forego their insulin or to ration doses, risking greater health problems. The cause? Insufficient prescription drug coverage by insurance carriers.Lost in this complex world of diabetes, amid the blame game and finger-pointing, are programs created by pharmaceutical manufacturers to help patients enrolled in private health insurance plans who cannot afford their prescriptions. Many insurers fail to tell people about these programs.Copay assistance cards, also called copay coupons, can help take the financial sting out of the cost of medication. To obtain one, patients must go to the insulin manufacturer’s website and search for financial or copay assistance programs, complete an application, and enroll.All of this can be a bit complicated; many people get frustrated and give up. Don’t!The value of copay assistance is this: it lowers the cost you pay and may even cover all the cost. The pharmaceutical company covers the difference. Typically, you don’t even have to prove that paying your regular copay would present a financial hardship. These programs are usually not available to Medicare recipients, however.To help people in the California Central Valley afford their insulin, we looked up programs offered by pharmaceutical companies that manufacture insulin.For more information on Insulin Support Programs, visit cover close to 100 percent of the cost. The Mat.org website is a great website to help you.Before filling your insulin prescription or any prescription medication, check to see if the pharmaceutical manufacturer offers a copay assistance program. If you need help, remember that your pharmacist is another excellent resource and may be able to answer your questions.Jeffrey Lewis is president and CEO of Legacy Health Endowment in Turlock Ca.Mr. Lewis’ email address is jeffrey@legacyhealthendowment.org
Taking Control of Distressing Low Sexual Desire: A Patient’s Journey
(NewsUSA) – For Amy, living with acquired generalized hypoactive sexual desire disorder (HSDD) was stressful. Acquired, generalized HSDD means that you have not had low sexual desire in the past and that you now have low sexual desire, no matter the sexual activity, situation, or sexual partner.She and her husband tried different types of stimulation, but nothing got her in the mood. "My lack of interest in sex was hard on my marriage. My husband wanted to be intimate, but I didn’t. I missed that connection with him."Amy is not alone in her experience. HSDD is a diagnosable medical condition that affects approximately 1 in 10 women in the U.S., with a profound impact on a woman’s emotional state, her sense of self and her relationships."Trying to deal with the strain of low sexual desire was difficult. I talked to my husband about it and we looked for solutions together. Eventually, my doctor helped me enroll in a clinical trial for an HSDD investigational treatment.""In the clinical trial, I received training on how to use an autoinjector to take the medicine at least 45 minutes before I anticipated sexual activity. I found the injection easy to use, it fit conveniently into my schedule and it put me in the driver’s seat for when I wanted to take the medication. I felt empowered when my desire returned and started to look forward to being intimate with my husband again."Following the clinical trial, Amy hoped she would one day have the choice of taking the medication again. In June 2019, the U.S. Food and Drug Administration (FDA) approved Vyleesi™ (bremelanotide injection) to treat hypoactive (low) sexual desire disorder (HSDD) in certain premenopausal women. Vyleesi is not indicated for the enhancement of sexual performance, but women will have another treatment option for HSDD when Vyleesi is available later this month.In the clinical trials, the most common side effects were nausea, flushing, injection site reactions, headache and vomiting. Vyleesi should not be used by women with uncontrolled high blood pressure or heart disease.AMAG Pharmaceuticals, the company launching Vyleesi, will offer co-pay assistance to help women access Vyleesi. Patients will be able to obtain their first four-pack of Vyleesi autoinjectors with a $0 co-pay, and refills for no more than $99. Under current government regulations, pharmaceutical companies cannot offer this type of program to patients insured by federal health care programs, including Medicare and Medicaid.Amy says, "I am motivated to share my story because I want to encourage other women to talk to their healthcare providers about distressing low sexual desire and find out what treatment options are available. They should know they do not have to suffer in silence."Women who may be experiencing symptoms are encouraged to visit Vyleesi.com and utilize a tool called the HSDD Symptom Checker. To verify diagnosis and to see if Vyleesi might be an appropriate treatment option for them, women are encouraged to speak with their healthcare provider (HCP). An open and honest conversation between a woman and her HCP is the first step to improving desire, reducing distress and getting back to a fulfilling sex life – something all women deserve.IMPORTANT SAFETY INFORMATIONDo not use VYLEESI if you have uncontrolled hypertension, known heart disease or are taking oral naltrexone-containing products intended to treat opioid or alcohol addiction. Women who can become pregnant should use effective birth control during treatment with VYLEESI.VYLEESI can cause serious side effects, including temporary increase in blood pressure and decrease in heart rate, severe nausea, and skin darkening that might be permanent.The most common side effects of VYLEESI include nausea, flushing, injection site reactions, headache, and vomiting. But these are not all the possible side effects of VYLEESI; consult your healthcare professional for more information or visit Vyleesi.com for additional Important Safety Information.You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.
Taking Control of Distressing Low Sexual Desire: A Patient’s Journey
(NewsUSA) – For Amy, living with acquired generalized hypoactive sexual desire disorder (HSDD) was stressful. Acquired, generalized HSDD means that you have not had low sexual desire in the past and that you now have low sexual desire, no matter the sexual activity, situation, or sexual partner.She and her husband tried different types of stimulation, but nothing got her in the mood. "My lack of interest in sex was hard on my marriage. My husband wanted to be intimate, but I didn’t. I missed that connection with him."Amy is not alone in her experience. HSDD is a diagnosable medical condition that affects approximately 1 in 10 women in the U.S., with a profound impact on a woman’s emotional state, her sense of self and her relationships."Trying to deal with the strain of low sexual desire was difficult. I talked to my husband about it and we looked for solutions together. Eventually, my doctor helped me enroll in a clinical trial for an HSDD investigational treatment.""In the clinical trial, I received training on how to use an autoinjector to take the medicine at least 45 minutes before I anticipated sexual activity. I found the injection easy to use, it fit conveniently into my schedule and it put me in the driver’s seat for when I wanted to take the medication. I felt empowered when my desire returned and started to look forward to being intimate with my husband again."Following the clinical trial, Amy hoped she would one day have the choice of taking the medication again. In June 2019, the U.S. Food and Drug Administration (FDA) approved Vyleesi™ (bremelanotide injection) to treat hypoactive (low) sexual desire disorder (HSDD) in certain premenopausal women. Vyleesi is not indicated for the enhancement of sexual performance, but women will have another treatment option for HSDD when Vyleesi is available later this month.In the clinical trials, the most common side effects were nausea, flushing, injection site reactions, headache and vomiting. Vyleesi should not be used by women with uncontrolled high blood pressure or heart disease.AMAG Pharmaceuticals, the company launching Vyleesi, will offer co-pay assistance to help women access Vyleesi. Patients will be able to obtain their first four-pack of Vyleesi autoinjectors with a $0 co-pay, and refills for no more than $99. Under current government regulations, pharmaceutical companies cannot offer this type of program to patients insured by federal health care programs, including Medicare and Medicaid.Amy says, "I am motivated to share my story because I want to encourage other women to talk to their healthcare providers about distressing low sexual desire and find out what treatment options are available. They should know they do not have to suffer in silence."Women who may be experiencing symptoms are encouraged to visit Vyleesi.com and utilize a tool called the HSDD Symptom Checker. To verify diagnosis and to see if Vyleesi might be an appropriate treatment option for them, women are encouraged to speak with their healthcare provider (HCP). An open and honest conversation between a woman and her HCP is the first step to improving desire, reducing distress and getting back to a fulfilling sex life – something all women deserve.IMPORTANT SAFETY INFORMATIONDo not use VYLEESI if you have uncontrolled hypertension, known heart disease or are taking oral naltrexone-containing products intended to treat opioid or alcohol addiction. Women who can become pregnant should use effective birth control during treatment with VYLEESI.VYLEESI can cause serious side effects, including temporary increase in blood pressure and decrease in heart rate, severe nausea, and skin darkening that might be permanent.The most common side effects of VYLEESI include nausea, flushing, injection site reactions, headache, and vomiting. But these are not all the possible side effects of VYLEESI; consult your healthcare professional for more information or visit Vyleesi.com for additional Important Safety Information.You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.
Need for Donor Registry Prompts Nobel Nomination
(NewsUSA) – When Dr. Bart Fisher’s son, Ivan, was diagnosed with a rare blood disorder in 1983 at eight-years-old, the only cure was a bone marrow transplant. However, at that time, there was only a small bone marrow registry in England, with 50,000 names and, in the U.S., no registry at all to find a match.Since Ivan’s death, Dr. Fisher has made it his mission to establish large marrow registries around the world that would provide the gift of life to those in need of marrow transplantation.Underscoring the need for a donor registry is the fact that every nine minutes an American dies from a blood cancer such as leukemia, lymphoma, or myeloma. In 2018 alone, there were 174,250 new blood cancer cases."I tried to take a personal disaster and turn it into a mechanism that could save the lives of others needing a marrow match," says Dr. Fisher, a Washington D.C. lawyer, and PhD.Now, due in large part to Dr. Fisher’s efforts, the National Marrow Donor Program and other marrow registries match voluntary marrow donors with patients in need of a bone marrow transplant, as well as those who have marrow failure. Since the formation of the program in 1986, more than 80,000 transplants have taken place as a result of matches found by marrow registries and over 6,200 transplants a year are performed.According to Dr. Robert K. Stuart, Ivan’s doctor, the registry was needed long before it became a reality."The skeptics said we need to develop the technology before we would be ready for a registry. But what people don’t realize is that creating the registry is what drove the technology development. We would not be where we are if we had waited to create the registry later," he says.In addition to his work to create an international registry, Dr. Fisher co-founded the Give Life Foundation, which seeks to expand the base of voluntary organ donors for the worldwide registries. In turn, the Foundation has launched the Swab for Life campaign, a program that promotes registries through pharmacies, dentists’ offices, and doctors’ offices.For his tireless efforts, the Aplastic Anemia and MDS International Foundation (AAMDS) has nominated Dr. Fisher, its founder and a member of its Board of Directors, for a 2019 Nobel Prize in two categories: peace and medicine."The Nobel Prize nomination recognizes the significant contributions of Dr. Fisher to the establishment and growth of marrow registries around the world, and we are pleased and honored to support his efforts to advance this life-saving cure for aplastic anemia, leukemia, and other blood cancers," says Neil Horikoshi, executive director and CEO of the Aplastic Anemia and MDS International Foundation."I am honored to receive this nomination on behalf of my son, knowing that the work I have done has helped thousands of people in need. That it will continue to save lives is a legacy to Ivan’s memory."To find out more about the Foundation and its mission, as well as resources available, visit
